drug · small molecule
patient view →glatiramer acetate ER
Phase 2updated 2mo agoby Mapi Pharma Ltd🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for multiple sclerosis and neoplasm and 8 investigational indications.
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that